Thursday, December 4, 2008

Uterine Fibroid Treatment at Emory

By Kara Thelen

Once upon a time, the hysterectomy was the only option for women suffering from uterine fibroids but now there are new options available. First though, it is important to know what these things are, how they form, and how to cure them. Much like several other medical conditions, the best thing that you can do is consult a doctor and ask for a professional opinion and information.

Uterine fibroids are classified as noncancerous growths that form on the wall of the uterus. They are quite common but in some cases can lead to pain, discomfort, and other problems. Irregular and prolonged menstrual bleeding, pelvic pain or pressure, lower back pain, constipation, frequent urination, and painful intercourse can all also be caused by uterine fibroids.

Some fibroids are quite large and some are smaller. They range in size from that of a pencil eraser to the size of a grape fruit and some have gotten even larger than that. Roughly 40% of all women will get uterine fibroids before they enter menopause, and that number swells to 50% if you are African American.

The Uterine fibroid embolization procedure is performed through a small puncture in an artery in the lower abdomen- typically the groin region. Medical dye is injected into the site to help identify the blood vessels supplying the uterus and also the uterine fibroids. Before embolization begins, the doctor slides a wire and catheter through these vessels and injects microscopic particles. These block the supply of blood to the uterine fibroids, causing them to shrink and eventually disappear over time.

As you can see, the treatments for uterine fibroids have evolved over the years and hysterectomy is no longer the last option. If you are noticing pain, discomfort, or any of the symptoms noted above then you should schedule an appointment with a doctor soon. When doing so, do not forget to ask about the Uterine Fibroid Embolization procedure that Emory Healthcare has pioneered.

About the Author:

No comments: